Skip to content
Citation only via OpenAlex

Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration

Robert L. Avery, Dante J. Pieramici, Melvin Rabena, ALESSANDRO A. CASTELLARIN, Ma'an A. Nasir, Matthew J. Giust

Ophthalmology · 2006 · ▲ 1,133 citations

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1016/j.ophtha.2005.11.019
Canonical
link ↗
Fetched
2026-10-19 MST

Cite this

APA
Avery, R.L., Pieramici, D.J., Rabena, M., CASTELLARIN, A.A., Nasir, M.A., &amp; Giust, M.J. (2006). Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration. <em>Ophthalmology</em>. https://doi.org/10.1016/j.ophtha.2005.11.019
Vancouver
Avery RL, Pieramici DJ, Rabena M, CASTELLARIN AA, Nasir MA, Giust MJ. Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration. Ophthalmology. 2006. doi:10.1016/j.ophtha.2005.11.019.
BibTeX
@article{robert2006Intrav, title = {Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration}, author = {Robert L. Avery and Dante J. Pieramici and Melvin Rabena and ALESSANDRO A. CASTELLARIN and Ma'an A. Nasir and Matthew J. Giust}, journal = {Ophthalmology}, year = {2006}, doi = {10.1016/j.ophtha.2005.11.019}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings